Application Nr Approved Date Route Status External Links
ANDA206392 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Aspirin And Extended-Release Dipyridamole Capsules Are Indicated To Reduce The Risk Of Stroke In Patients Who Have Had Transient Ischemia Of The Brain Or Completed Ischemic Stroke Due To Thrombosis. • Aspirin And Extended-Release Dipyridamole Capsules Are A Combination Antiplatelet Agent Indicated To Reduce The Risk Of Stroke In Patients Who Have Had Transient Ischemia Of The Brain Or Completed Ischemic Stroke Due To Thrombosis. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Aspirin ASPIRIN ZINC53
2. Dipyridamole DIPYRIDAMOLE ZINC643046

Comments